Skip to main content
Premium Trial:

Request an Annual Quote

DNAVision to Install Illumina HiScanSQ for GWAS Projects

Premium

This article was originally published May 17.

Belgian genomic service provider DNAVision said this week that it is purchasing an Illumina HiScanSQ microarray scanning and sequencing instrument for its Gosselies facility.

The company plans to use the new instrument initially for genome-wide association studies for its pharmaceutical and medical research customers.

The new platform, which DNAVision said will be the first HiScanSQ for commercial use in Europe, will add to the firm's existing next-gen sequencing services on the Illumina HiSeq 2000, Illumina GAIIx, and Roche 454 GS FLX, and to its array services using Illumina, Agilent, and Affymetrix microarrays.

DNAVision is ISO17025-accredited, CLIA-certified, CAP-accredited, GLP-certified, and GMP-certified.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.